Biacore, Bioreason other research news

The partners presented data showing that the combination of BCOR's surface plasmon resonance (SPR)-based biosensor technology and Bioreason's predictive chemoinformatics software identified molecular groups that affect a compound's ability to bind to human serum albumin, a major component of human plasma. They suggested that binding to plasma proteins often is an unwanted property of lead compounds. Data were presented at the Society for Biomolecular Screening conference in Vancouver. ...